Syndrome | Suggested therapy |
---|---|
Gastroenteritis | |
Normal host | Rehydration |
Normal host with severe disease or risk factors | Levofloxacin, 500 mg (or other fluoroquinolone) once a day for 7–10 d; or azithromycin, 500 mg once a day for 7 d |
Immunocompromised adult | Levofloxacin, 500 mg (or other fluoroquinolone) once a day for 14 days; or azithromycin, 500 mg once a day for 14 d |
Neonate or immunocompromised child | None or ceftriaxone, 100 mg/kg/d in two equally divided daily doses for 7–10 d; or azithromycin, 20 mg/kg/d once a day for 7 d |
Typhoid fever | |
Adult, sensitive strain | Ciprofloxacin, 500 mg PO or IV BID for 5–7 d |
Adult, intermediate strainsa | Ciprofloxacin, 750 mg PO or IV BID for 5–7 d |
Adult, resistant strainsb | Ceftriaxone, 2 g IV qd for 10–14 d; or azithromycin, 500 mg PO or IV qd for 7 d |
Children, pregnant women | Ceftriaxone, 100 mg/kg/d in two equally divided daily doses for 10–14 d; or azithromycin, 20 mg/kg/d once a day for 7 d |
All patients with severe typhoid fever (delirium, obtundation, stupor, coma, or shock) should receive dexamethasone, 3 mg/kg initially, followed by 1 mg/kg q6h for 48 h | |
Chronic carrier | |
Adult | Ciprofloxacin, 750 mg PO BID for 4 wk; or amoxicillin, 1 g PO TID for 3 mo; or TMP–SMX, 160/800 mg PO BID for 3 mo |
Children | Amoxicillin, 40 mg/kg PO up to 1 g TID for 3 mo; or TMP–SMX, 5 mg/kg TMP BID for 3 mo |
Abbreviations: TMP–SMX = trimethoprim–sulfamethoxazole; MIC = minimum inhibitory concentration.
Typhoid fever
Fluoroquinolones are the agents of choice for treatment of typhoid fever. They are more rapidly effective and are associated with lower rates of relapse and stool carriage than chloramphenicol, ampicillin, and TMP–SMX. They are also felt to be more effective than ceftriaxone. Strains sensitive to nalidixic acid can be treated with